Maternal asthma medication use during pregnancy and risk of congenital heart defects.

about

Consistency of maternal telephone administration of the asthma control test using postpartum recall compared to repeated measures during pregnancy.

P2860

Q39428142-C823B0D0-2EC4-4820-B688-5E64B8DC0098

P2860

Maternal asthma medication use during pregnancy and risk of congenital heart defects.

Item

http://www.wikidata.org/entity/Q41312430

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Maternal asthma medication use during pregnancy and risk of congenital heart defects.

@en

type

Item

label

Maternal asthma medication use during pregnancy and risk of congenital heart defects.

@en

prefLabel

Maternal asthma medication use during pregnancy and risk of congenital heart defects.

@en

P1476

Maternal asthma medication use during pregnancy and risk of congenital heart defects.

@en

P2093

Alissa R Van Zutphen

http://www.w3.org/2001/XMLSchema#string

Angela E Lin

http://www.w3.org/2001/XMLSchema#string

Charlotte M Druschel

http://www.w3.org/2001/XMLSchema#string

Erin M Bell

http://www.w3.org/2001/XMLSchema#string

Marilyn L Browne

http://www.w3.org/2001/XMLSchema#string

P2860

Asthma in pregnancy and its pharmacologic treatment

The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis

Cardiovascular anomalies associated with prenatal exposure to theophylline

The efficacy and safety of asthma medications during pregnancy.

Management of rhinitis and asthma in pregnancy.

The National Birth Defects Prevention Study.

NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update.

Asthma during pregnancy: mechanisms and treatment implications.

The management of asthma and rhinitis during pregnancy.

Treatment of asthma during pregnancy and perinatal outcomes.

P304

951-961

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BDRA.23437

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Shao Lin

National Birth Defects Prevention Study

P577

2015-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26408052

http://www.w3.org/2001/XMLSchema#string

P921

birth defect

Maternal asthma medication use during pregnancy and risk of congenital heart defects.

about

P2860

P2860

Maternal asthma medication use during pregnancy and risk of congenital heart defects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921